Industri

CDSCO West Zone to conduct webinar on WHO-GMP and COPP ...

Refresher session scheduled on April 29 for industry members and regulators The...

Dr Reddy’s receives Health Canada approval for generic ...

Market authorisation covers 2 mg and 4 mg pen presentations in Canada The post...

Chris Jann Joins Minneapolis Office of Wold

Wold Architects & Engineers, a full-service planning, architecture and engineeri...

Maintaining Quality: Origin’s Guide to Keeping Medical ...

As the commonality of medical cannabis continues to increase in the UK, keeping ...

FDA approves AstraZeneca’s Saphnelo for SLE

The approval allows adults with SLE on standard therapy to inject Saphnelo thems...

BioMarin acquires Amicus Therapeutics for $4.8bn

The deal was originally announced in December 2025. With the acquisition, BioMar...

VESCOP, ENTOD and APTI Maharashtra host Vision 360 symp...

Symposium focuses on translating research into clinical application in ophthalm...

Express Pharma World Expo 2027

Where the future of Indian Pharma takes shape. The post Express Pharma World Ex...

Alvarez & Marsal India appoints Nitin Lath as MD in Cor...

Appointment to focus on private equity and M&A advisory in life sciences secto...

AKUMS launches Aztreonam-Avibactam Injection for multid...

Therapy targets gram-negative bacterial infections in critical care settings Th...

Mary Bridge Children’s Hospital to Celebrate Grand Open...

Mary Bridge Children’s Hospital is preparing for the grand opening of its new st...

Drug Product Loss: Understanding Yield

How much drug product loss should you expect in fill-finish? Drug product loss i...

Novartis secures pair of regulatory wins for skin disea...

The European Commission (EC) has approved Novartis’ Rhapsido (remibrutinib) for ...

Sun Pharma to acquire Organon for $11.75bn

Organon, created through a spinoff from Merck & Co (MSD) in 2021, distributes mo...

Zydus receives approval to conduct Phase III trials of ...

Two studies to evaluate efficacy and safety in Plasmodium falciparum and Plasmo...

Boehringer Ingelheim India, NIPER Hajipur sign MoU for ...

Five-year agreement focuses on open science access, joint research and capabili...